Navigation Links
Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
Date:12/9/2007

LOS ANGELES, Dec. 9 /PRNewswire/ -- A federal court in Los Angeles has opened the door to shining a harsh spotlight on the pharmaceutical firm Johnson & Johnson, whose subsidiary McNeil Nutritionals has been accused of false advertising the controversial chemical sweetener Splenda. United States District Dale S. Fischer rejected Johnson & Johnson's request for summary judgment based on that charge that the plaintiffs had unreasonably delayed bringing suit, and said that the claims against Johnson & Johnson should be heard by a jury at a trial on the merits.

Andy Briscoe, President and CEO of the Washington-based Sugar Association, representing thousands of sugar farmers from across the nation, declared, "This ruling will give consumers a chance to hear the facts in this case. Consumers have a right to know what they really are buying and an equal right not to have a big corporation try to tell them something else. We look forward to the trial."

The central issue before the court is the deceptive nature of the advertising of Splenda -- a chemical sweetener -- to make consumers believe it is a natural product, including the use of the taglines, "Made from sugar, so it tastes like sugar" and "Good for the Whole Family." Internal documents show Johnson & Johnson knew that its Splenda advertising was causing consumers to believe that Splenda, which is made using chlorine, is a natural product, despite it being chemical. Although rulings in France, Australia and New Zealand have found Johnson & Johnson's advertising of Splenda to be deceptive, the company continues to falsely promote Splenda as something that it is not.

Dan Callister, attorney for the Sugar Association, said, "We believe that the facts in this case are clear and compelling. For the second time, a jury will find that Johnson & Johnson has intentionally misled the consumer in its marketing of the chlorinated sweetener Splenda."

It has been estimated that damages in this case could reach $1-billion. The trial currently is scheduled to begin on January 29, 2008, in Los Angeles. Additional background information can be found at http://www.TruthAboutSplenda.com .


'/>"/>
SOURCE Sugar Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
2. MDMA Names New Director of Federal Affairs
3. Federal research plan to determine nanotech risks fails to deliver
4. Federal Employee Program Maintains Low Health Premiums In 2008
5. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
6. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
7. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
8. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
9. HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... , ... An inventor and manicurist from Greet, S.C., wants to offer people a new way ... maintain clean and healthy feet, so I know the importance of proper foot care," he ... designed the FOOT-TRAN SYSTEM." , The FOOT-TRAN SYSTEM enables a user to clean and exfoliate ...
(Date:3/30/2017)... ... March 30, 2017 , ... This ... to President Trump expressing their support for an independent Vaccine Safety Commission. Five ... and one medical journalist, will hold a press conference at 9:00 AM ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... In the ... to 300,000 people each year develop other types of metastatic brain tumors(3). Though most ... the brain(3). As efforts focus on finding more effective treatment options, the San ...
(Date:3/29/2017)... ... ... the main cause of hay fever in the United States, with an estimated 95 percent ... to July each year; with the worst time for sufferers being June and July. ... ) provide an effective defense against grass pollen; they are proven in independent studies to ...
(Date:3/29/2017)... St. Petersburg, FL (PRWEB) , ... March 30, 2017 , ... ... Often called the "Spice of Life" or "Wonder Spice", it has been used for ... extensive use in the East," says Heshelow, author of " Turmeric: How to Use ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Treated at Proton Therapy Centers & Forecast" report to their offering. ... The South Korean Proton ... market size in 2016. The Untapped Proton Therapy Market for ... in 2016. Proton Therapy plays an important role in ...
(Date:3/29/2017)... , March 29, 2017  Experts in the ... monitoring devices like  Soberlink Systems  as a model ... paper, published in early 2017, concluded that remote ... in managing patient recovery." The findings ... of Addiction Medicine, detail a range of variables ...
(Date:3/29/2017)... Calif. , March 29, 2017 ... for patients as the highest standard in quality ... Krypton Vision introduces its objective Wavefront-driven refraction technologies ... subjective approach. This enables an unprecedented level of ... - exceptional vision relegated to Topgun Navy fighter ...
Breaking Medicine Technology: